Porphyromonas gingivalis

Measures antibodies against 32 different pathogens that may lead to autoimmune reactivities, including oral pathogens, gut pathogens, Mycoplasma, Chlamydia, Mycobacterium avium, Candida albicans, mycotoxin-producing molds (Aspergillus, Penicillium, Stachybotrys), EBV, CMV, HHV-6, and the agent and co-infections of Lyme disease. Detects possible associations between different bacteria, viruses, parasites, yeasts, and molds with more than 80 different autoimmune diseases due to cross-reactivity and molecular mimicry. It can also be used to monitor the effectiveness of various protocols in the management of autoimmune disorders triggered by pathogens. Developed and published by Aristo Vojdani, PhD, MSc, CLS, known as the father of functional immunology, in 2006, 2009, 2014, 2015, 2018, 2021, and 2024.

The BiomeFx examines the balance of pathogens and beneficial microbes that make up the microbiome and reports the potential functions of microbes to understand how the microbiome could impact symptoms and health concerns. It also provides nutrition, lifestyle, and supplement recommendations to improve the balance of the microbiome.

The Bristle Oral Microbiome Test is a comprehensive oral microbiome test that utilizes NGS technology to identify and measure bacteria, fungi, and more from a saliva sample, allowing practitioners to measure oral health status, identify oral conditions, and create personalized treatment protocols. This test cannot be ordered for patients under 16 years of age.

This test uses US BioTek's advanced quantitative PCR technology to analyze the oral microbiome, crucial for understanding and managing both local dental issues and systemic health conditions. This testing offers vital insights for improving oral health through targeted dietary and lifestyle changes.